Skip to content

Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment

Dr Onyema Ogbuagu at a media briefing at CROI 2025. He is sitting between two people and talking into a microphone.

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

Professor Sarah Fidler at a media briefing at CROI 2025. She is talking into a microphone.

Radical changes in US policy threaten two decades’ progress in HIV

Professor Chris Beyrer presenting at CROI 2025. He is standing at a lectern in front of a screen.

Two more people with HIV may be cured after stem cell transplants

Two people at a media briefing at CROI 2025. Dr Paul Rubinstein (on the right) is talking into a microphone and Dr Marius Trøseid is next to him.

aidsmap returns with reporting from the Conference on Retroviruses and Opportunistic Infections (CROI)

aidsmap returns with reporting from the Conference on Retroviruses and Opportunistic Infections (CROI)

Accessible HIV science is vital in an age of disinformation

aidsmap logo

Public Statement: Transition of Aidsmap and NAM Publications' Assets to Terrence Higgins Trust and National AIDS Trust

Public Statement: Transition of Aidsmap and NAM Publications' Assets to Terrence Higgins Trust and National AIDS Trust

Second woman possibly cured of HIV

A conference room with poster panels, and attendees moving between them

The long-acting HIV treatment era is just beginning

Professor José Arribas, Research Director of HIV and Infectious Diseases at La Paz Hospital, Madrid